CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 28.38

Change

-0.25 (-0.87)%

Market Cap

USD 0.28B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.14 (+0.26%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

N/A

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.06 (+0.19%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.30 (+1.20%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.14 (-0.31%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.76 (+0.53%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.28%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.91 (+0.85%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.54 (+1.06%)

USD 80.38B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.36% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.36% 95% A 92% A
Trailing 12 Months  
Capital Gain 44.99% 94% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.99% 94% A 92% A
Trailing 5 Years  
Capital Gain 34.57% 61% D- 63% D
Dividend Return 4.41% 20% F 17% F
Total Return 38.98% 60% D- 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 2.14% 33% F 35% F
Dividend Return 2.38% 34% F 35% F
Total Return 0.24% 27% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 17.97% 24% F 37% F
Risk Adjusted Return 13.27% 27% F 30% F
Market Capitalization 0.28B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.